Antigenics (AGEN) Posts Q3 Loss of $0.13, Revs Up Y/Y
AGEN Hot Sheet
EPS Growth %: -480.0%Financial Fact:
Operating loss: 7.8M
Today's EPS Names:
VSNT, CIM, KH, More
Antigenics Inc. (NASDAQ: AGEN) reports Q3 loss of $0.13, compared to ($0.17) in the same quarter last year. Revenue for the quarter was $896 million, versus $685 million in Q308.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
